ORLEANS, ON, Oct. 15, 2018 /CNW/ - 

Recent live and pre-taped media experience:     

• BNN/Bloomberg
• Business of Cannabis
• CJAD
• TVA

Background:               

• Tetra Bio-Pharma is a global leader in the discovery and development of cannabis and cannabinoid drugs. www.tetrabiopharma.com
• Tetra is the only company in North America working with Health Canada and the FDA on clinical trial programs that lead to prescription cannabis drugs.
• Dr. Chamberland has 22 + years of experience in drug development expertise in regulatory affairs, and the development and management of clinical research protocols and clinical studies for botanical medicines.
• He is fluently bilingual and a recognized expert in botanical medicine, publishing, lecturing and delivering continuing education workshops on the use of plants in the treatment of such areas as pain, anxiety, insomnia, and wound healing.
• He is Professor of Botanical Medicine and Principles of clinical research at the Ecole d'Enseignement Superieur de Naturopathie du Quebec (EESNQ).

Topics:

• Is there a way to consume recreational cannabis safely?
• If you have a health condition and plan to use recreational cannabis – what are the risks?
• Should we expect an increase in ER visits after October 17 and why?
• Should we worry about the lack of scientific evidence to prove the safety and efficacy of cannabis?
• Will doctors, regulators like Health Canada and bodies like the Canadian Medical Association ever approve cannabis use?
• How far is Canada/the US away from having cannabis in pharmacies, and covered by insurance?

An excellent speaker, Dr. Chamberland is available for media appearances in the Montreal/Southern Ontario region.

SOURCE Tetra Bio-Pharma

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/15/c2235.html